EUVIMEDEUVIMED entdecken
Crossref

Selective VRK1 inhibition reduces glioblastoma growth via synthetic lethality in vitro and in vivo

M. Singh, S. Moussaud, L.B. Persson, L. Tresaugues, K. Roos, V.O. Talibov, M. Stantic, G. Gudoityte, A.D. Milito, J. Lindström, M. Andersson

European Journal of Cancer · 2026-11 · 248 · 117630

DOI: 10.1016/j.ejca.2026.117630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von M. Singh und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Singh, M., Moussaud, S., Persson, L., Tresaugues, L., Roos, K., Talibov, V., Stantic, M., Gudoityte, G., Milito, A., Lindström, J., & Andersson, M. (2026). Selective VRK1 inhibition reduces glioblastoma growth via synthetic lethality in vitro and in vivo. European Journal of Cancer, 248, 117630. https://doi.org/10.1016/j.ejca.2026.117630

Vancouver

Singh M, Moussaud S, Persson L, Tresaugues L, Roos K, Talibov V, et al. Selective VRK1 inhibition reduces glioblastoma growth via synthetic lethality in vitro and in vivo. European Journal of Cancer. 2026;248:117630. doi:10.1016/j.ejca.2026.117630

BibTeX
@article{Singh2026,
  author = {Singh, M. and Moussaud, S. and Persson, L.B. and Tresaugues, L. and Roos, K. and Talibov, V.O. and Stantic, M. and Gudoityte, G. and Milito, A.D. and Lindström, J. and Andersson, M.},
  title = {Selective VRK1 inhibition reduces glioblastoma growth via synthetic lethality in vitro and in vivo},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117630},
  doi = {10.1016/j.ejca.2026.117630}
}
Kostenlos starten →